Trials / Completed
CompletedNCT03867656
Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 25 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Both GLP-2 and GIP reduce the bone resorption (measured as CTX) in healthy persons. In this study, we will investigate wether GLP-2 and GIP is reducing CTX in persons with type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GLP-2 | GLP-2 injection |
| OTHER | GIP | GIP injection |
| OTHER | Placebo | Placebo injection |
Timeline
- Start date
- 2019-02-26
- Primary completion
- 2020-06-26
- Completion
- 2020-06-26
- First posted
- 2019-03-08
- Last updated
- 2020-11-04
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03867656. Inclusion in this directory is not an endorsement.